hepatology
美 [hepə'tɒlədʒɪ]英 [hepə'tɒlədʒɪ]
- n.【医】肝病专科
- 网络肝脏病学；肝脏学；肝病学
hepatologyhepatology
肝脏病学
去年，Kim等人在《肝脏病学》（Hepatology）杂志上发表了一篇题为“Sixty-five gene-based risk scoreclassifier predicts overal…
肝脏学
肝脏学（Hepatology）在我国是一门比较年轻的分支学科。我国从事肝脏学研究的机构和队伍相对比较薄弱，大多从内科、传 …
肝病学
在1997年肝病学(Hepatology)中，有一篇关於预防性食道静脉结紮的文献。接受这种治疗的病患，两年内的再出血率，会从60…
肝病专科
急诊科翻译为英语叫什么？_百度知道 ... Hematology 血液科 Hepatology 肝病专科 Infectious Disease 传染病科 ...
肝脏病学杂志
在美国肝脏病学杂志（Hepatology）2009年第4期，有2篇论文深入地探讨了聚乙二醇干扰素治疗HBeAg阴性肝炎过程中检测HB…
肝脏病学期刊
这项研究发表於今年1月号的「肝脏病学期刊」（Hepatology）。肝脏纤维化或产生疤痕时，表示肝脏疾病已经迈入第二阶段， …
1
HEPATOLOGY DIGEST: Right, so through these integrative efforts we might be able to control the progression of liver cancer, right?
《国际肝病》：那么是不是通过这些综合治疗手段我们就可能控制肝癌的进展？
2
Hepatology Digest: Thank you both. It was a pleasure and I hope to see you next year.
国际肝病：感谢二位，非常高兴，希望明年再次见面。
3
Hepatology Digest: The last thing I would like to ask you about is sorafenib .
国际肝病：最后我想问的是索拉非尼。
4
Hepatology Digest: how do you think the clinical practice of proteinase inhibitors ? Will the side effects affect its clinical use?
《国际肝病》：您怎样看待蛋白酶抑制剂在临床上的应用以及这些药物的副作用？
5
Hepatology Digest: The liver is known as an immunologically privileged organ in solid organ transplants.
《国际肝病》：在实体器官移植中，肝脏被称为免疫特惠器官。
6
Hepatology Digest: From your experience, RFA is an efficient treatment for HCC. What are the indications and contraindications for RFA?
《国际肝病》：从您的经验来看，RFA是一种治疗肝细胞癌的有效方法。那么RFA的适应证和禁忌证有哪些？
7
Hepatology Digest: The reason I ask is that there is a bit of a mixed message here. Red wine is promoted as a good anti-oxidant for example.
《国际肝病》：之所以我这么问是有一点潜藏在这里，例如红酒被作为一种良好的抗氧化。
8
Hepatology Digest: Professor Jia, do you know of any similar compounds that are being researched in China?
《国际肝病》：贾教授，就您所知，是否有其他类似化合物在中国正在被研究呢？
9
Hepatology Digest: It seems that most people today don't recommend switching at this point and it is more of an add-on strategy.
肝病文摘：看来，大多数人今天不建议交换在这一点上，它更是一个附加的战略。
10
Hepatology Digest: The two approved DAA drugs, telaprevir and boceprevir, were thought of the first generation protease inhibitors.
《国际肝病》：已批准的两种DAA，telaprevir和boceprevir，是第一代蛋白酶抑制剂。
11
Hepatology Digest: For the treatment of chronic hepatitis B patients with cirrhosis what are the issues required for special intervention?
《国际肝病》：对于合并肝硬化的慢性乙型肝炎患者，我们需要特别注意什么？
12
Hepatology Digest : Could you tell us your opinion on the current state of affairs in the diagnosis of this pathology?
《国际肝病》：您是否能谈谈您在目前肝肺综合征诊断方面的观点？
13
Hepatology Digest: Amniotic fluid is said to contain a wide variety of useful cells. Could you comment about obtaining cells in this manner?
《国际肝病》：羊水里含有多种有价值的干细胞，能否请您就这种获取干细胞的方式做一评论？
14
Hepatology Digest: In the rest of the world, could you give us an update on how the hepatitis B vaccine is being applied?
《国际肝病》：您能谈一下世界其他地区乙肝疫苗接种的进展吗？
15
Hepatology Digest: When intra-uterine transmission happens, the vaccination and hepatitis B immunoglobulin might not be functional.
《国际肝病》：如果在子宫内发生了传染，可能疫苗和乙肝免疫球蛋白就会不起作用了。
16
Hepatology Digest: At present, interventional therapy is still the more effective treatment strategy for unresectable HCC patients.
国际肝病：对于无法手术切除的肝癌病人，介入治疗仍是目前较有效的治疗方法。
17
Department of Gastroenterology and Hepatology, National University Health System, Singapore, Singapore.
胃肠病学和肝病学系，新加坡，新加坡国立大学卫生系统。
18
Hepatology Digest: What are the differences between antiviral treatment in pre-transplant and post-transplant in HBV patients?
肝病文摘：之间有什么区别抗病毒治疗在移植前和移植后的HBV患者？
19
Hepatology Digest : Could you provide us an outline on the latest advancements on improving the management of this pathology?
《国际肝病》：您能否大概谈下目前肝肺综合征治疗方面的新进展？
20
Hepatology Digest: What advances in pharmacological treatment can halt progression to decompensated cirrhosis or reverse cirrhosis?
《国际肝病》：目前对于阻止失代偿肝硬化进展或逆转肝硬化有哪些药物治疗进展？
21
Hepatology Digest: There is now no effective treatment for Wilson's disease related liver cirrhosis besides liver transplantation.
国际肝病：除了肝移植外，目前还没有有效治疗Wilson病相关肝硬化的方法。
22
Hepatology Digest: You mentioned one of the hot topics is the direct antivirals.
《国际肝病》：您提到最热门的话题是直接抗病毒药物治疗。
23
Hepatology Digest: Individualized treatment is important for chronic hepatitis C using current available direct acting antivirals (DAA).
《国际肝病》：慢性丙型肝炎应用当前有效的DAA治疗，个体化治疗很重要。
24
Hepatology Digest: Can pre-transplantation antiviral treatment improve the post-transplantation survival rate?
《国际肝病》：请问移植前抗病毒治疗能改善移植后生存率吗？
25
Dept of Gastroenterology and Hepatology, National University Health System, Singapore, Singapore.
胃肠病学和肝病学系，新加坡，新加坡国立大学健康系统。
26
Hepatology Digest: Following up on that: you mentioned that in 2008 the pathogenesis of non-alcoholic steatohepatitis is not necessary know.
国际肝病：您提到非酒精性脂肪性肝炎的发病机制还不完全清楚。
27
Hepatology Digest : This year you conducted a prospective population-based surveillance to estimate newly diagnosed CLD incidence.
《国际肝病》：您今年开展了一项基于人群的前瞻性监测研究，以评估新近诊断的慢性肝病患病率。
28
Hepatology Digest: Do you think HCC is a major indication for living donor transplantation? Why or why not?
《国际肝病》：您认为HCC可以作为活体供肝肝移植的一个主要适应证吗？为什么？
29
Hepatology Digest: What would be your experience and approach Professor Xie?
《国际肝病》：谢教授您的经验呢？
30
Hepatology Digest: In the guideline, non-invasive markers may be used to measure liver disease.
《国际肝病》：指南中，非侵入性标记物可被用于评估肝病。